常染色体显性肾小管间质肾病中黏蛋白-1的双等位表达:对非遗传性疾病识别的意义
本研究评估了SNaPshot微测序检测MUC1突变及MUC1-fs免疫组化在ADTKD-MUC1诊断中的价值。在三个家系中,SNaPshot检测突变稳健;免疫组化显示MUC1定位于顶膜,MUC1-fs分布于细胞质,且能可靠预测患者疾病状态。结论认为免疫组化是ADTKD-MUC1非遗传诊断的可行方法。
要点
- SNaPshot微测序可稳健检测ADTKD-MUC1的MUC1突变。
- MUC1-fs免疫组化能可靠预测ADTKD-MUC1患者疾病状态。
- 肾活检免疫组化可作为ADTKD-MUC1非遗传诊断方法。
核心结论
- 免疫组化检测肾活检标本中MUC1-fs表达是ADTKD-MUC1非遗传诊断的可行方法,可用于筛选家系进一步诊断。
- 分子遗传学诊断ADTKD-MUC1可行但技术难度大且劳动强度高。
- 数据支持MUC1-fs的特定分子效应参与该病发病机制的假说。
研究设计与样本
- 研究重新评估了靶向重复富集和SNaPshot微测序通过微卫星分析单倍型重建在三个独立ADTKD-MUC1家系中检测MUC1突变。
- 研究制备了针对MUC1-fs的兔多克隆抗体,并在人肾活检标本中评估野生型和突变等位基因产物的免疫检测。
主要发现
- SNaPshot微测序检测MUC1突变稳健。
- 免疫染色显示MUC1和MUC1-fs在ADTKD-MUC1人肾中均可检测到,黏蛋白1定位于顶膜,MUC1-fs广泛分布于细胞质。
- 临床肾样本中MUC1-fs表达的免疫组化分析可可靠预测个体患者的疾病状态。
临床怎么用
- 对疑似ADTKD-MUC1患者,肾活检标本免疫组化检测MUC1-fs可用于非遗传诊断,并筛选家系进行进一步诊断。
局限性
- 分子遗传学诊断ADTKD-MUC1技术难度大且劳动强度高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Providing the correct diagnosis for patients with tubulointerstitial kidney disease and secondary degenerative disorders, such as hypertension, remains a challenge. The autosomal dominant tubulointerstitial kidney disease (ADTKD) subtype caused by MUC1 mutations (ADTKD-MUC1) is particularly difficult to diagnose, because the mutational hotspot is a complex repeat domain, inaccessible with routine sequencing techniques. Here, we further evaluated SNaPshot minisequencing as a technique for diagnosing ADTKD-MUC1 and assessed immunodetection of the disease-associated mucin 1 frameshift protein (MUC1-fs) as a nongenetic technique. METHODS: We re-evaluated detection of MUC1 mutations by targeted repeat enrichment and SNaPshot minisequencing by haplotype reconstruction via microsatellite analysis in three independent ADTKD-MUC1 families. Additionally, we generated rabbit polyclonal antibodies against MUC1-fs and evaluated immunodetection of wild-type and mutated allele products in human kidney biopsy specimens. RESULTS: The detection of MUC1 mutations by SNaPshot minisequencing was robust. Immunostaining with our MUC1-fs antibodies and an MUC1 antibody showed that both proteins are readily detectable in human ADTKD-MUC1 kidneys, with mucin 1 localized to the apical membrane and MUC1-fs abundantly distributed throughout the cytoplasm. Notably, immunohistochemical analysis of MUC1-fs expression in clinical kidney samples facilitated reliable prediction of the disease status of individual patients. CONCLUSIONS: Diagnosing ADTKD-MUC1 by molecular genetics is possible, but it is technically demanding and labor intensive. However, immunohistochemistry on kidney biopsy specimens is feasible for nongenetic diagnosis of ADTKD-MUC1 and therefore, a valid method to select families for further diagnostics. Our data are compatible with the hypothesis that specific molecular effects of MUC1-fs underlie the pathogenesis of this disease.
引用
- Knaup KX, Hackenbeck T, Popp B, et al. Biallelic Expression of Mucin-1 in Autosomal Dominant Tubulointerstitial Kidney Disease: Implications for Nongenetic Disease Recognition. J Am Soc Nephrol. 2018. PMID: 30049680. doi:10.1681/ASN.2018030245
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。